Greg Young is the Managing Partner and Co-Founder of Spruce Capital Partners, a San Francisco-based venture capital firm. See sector focus and contact routes.
Greg Young is the Managing Partner and Co-Founder of Spruce Capital Partners, a San Francisco-based venture capital firm, with over 18 years of experience in the biotechnology industry and a prior role as Managing Director at Burrill & Company. His investment thesis targets agriculture, renewable energy, chemicals, and biological tools that promote sustainability, focusing on the agriculture, nutrition, and industrial life sciences sectors across seed to Series B stages. While Spruce Capital Partners typically leads rounds with average check sizes of approximately $30 million for Series A and $22 million for Series B, Young’s specific lead or follow behavior is not explicitly detailed in available sources. His notable portfolio companies include Agerpoint and Crop Enhancement, for which he serves on the board, as well as Greenlight Biosciences and Provivi, where he observes board activities. Young is recognized as a thought leader in the biogreentech sector alongside fellow Spruce principals Dr. Ganesh Kishore and Dr. Roger Wyse. He holds a BS in Biochemistry and Cell Biology from UC San Diego and an MS in Biotechnology from Northwestern University, grounding his
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in San Francisco.
Investors like Greg Young · Full investor directory · Investor access · Company funding database